Transthyretin regulates the migration and invasion of JEG-3 cells

Oncology Letters

Volumn 13, Issue 3, 2017, Pages 1242-1246

  Gong, Liyun ^a   Zhu, Lei ^a   Wang, Shuzhen ^a   Zhang, Zhenyu ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Matrix metalloproteinase; Preeclampsia; Transthyretin; Trophoblast invasion

Indexed keywords

GELATINASE A; GELATINASE B; PREALBUMIN;

ARTICLE; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; TROPHOCYTE; UPREGULATION; WESTERN BLOTTING;

EID: 85011854066     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2016.5545     Document Type: Article

References (25)

1. ACOG Committee on Obstetric Practice; American College of Obstetricians and Gynecologists: ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. Int J Gynaecol Obstet 77: 67-75, 2002.
2. Duley L, Meher S and Abalos E: Management of pre-eclampsia. BMJ 332: 463-468, 2006.
3. Poon LC and Nicolaides KH: Early prediction of preeclampsia. Obstet Gynecol Int 2014: 297397, 2014.
4. Tal R: The role of hypoxia and hypoxia-inducible factor-1alpha in preeclampsia pathogenesis. Biol Reprod 87: 134, 2012.
5. Goldman-Wohl D and Yagel S: Regulation of trophoblast invasion: from normal implantation to pre-eclampsia. Mol Cell Endocrinol 187: 233-238, 2002.
6. Lam C, Lim KH and Karumanchi SA: Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia. Hypertension 46: 1077-1085, 2005.
7. Fruscalzo A, Schmitz R, Klockenbusch W, Köhler G, Londero AP, Siwetz M and Huppertz B: Human placental transthyretin in fetal growth restriction in combination with preeclampsia and the HELLP syndrome. Histochem Cell Biol 138: 925-932, 2012.
8. Chen Y and Zhang Z: Does transthyretin function as one of contributors for preeclampsia? Med Hypotheses 76: 8-10, 2011.
9. Huppertz B, Kertschanska S, Demir AY, Frank HG and Kaufmann P: Immunohistochemistry of matrix metalloproteinases (MMP), their substrates, and their inhibitors (TIMP) during trophoblast invasion in the human placenta. Cell Tissue Res 291: 133-148, 1998.
10. Hannan NJ, Paiva P, Dimitriadis E and Salamonsen LA: Models for study of human embryo implantation: choice of cell lines? Biol Reprod 82: 235-245, 2010.
11. Harris LK: Review: trophoblast-vascular cell interactions in early pregnancy: how to remodel a vessel. Placenta 31 (Suppl): S93-S98, 2010.
12. Hiden U, Bilban M, Knöfler M and Desoye G: Kisspeptins and the placenta: regulation of trophoblast invasion. Rev Endocr Metab Disord 8: 31-39, 2007.
13. Pennington KA, Schlitt JM, Jackson DL, Schulz LC and Schust DJ: Preeclampsia: multiple approaches for a multifactorial disease. Dis Model Mech 5: 9-18, 2012.
14. Kaitu'u-Lino TJ, Ye L, Tuohey L, Dimitriadis E, Bulmer J, Rogers P, Menkhorst E, Van Sinderen M, Girling JE, Hannan N, et al: Corin, an enzyme with a putative role in spiral artery remodeling, is up-regulated in late secretory endometrium and first trimester decidua. Hum Reprod 28: 1172-1180, 2013.
15. Ren L, Liu YQ, Zhou WH and Zhang YZ: Trophoblast-derived chemokine CXCL12 promotes CXCR4 expression and invasion of human first-trimester decidual stromal cells. Hum Reprod 27: 366-374, 2012.
16. Kim YJ: Pathogenesis and promising non-invasive markers for preeclampsia. Obstet Gynecol Sci 56: 2-7, 2013.
17. Liu X, Dai LI and Zhou R: Association between preeclampsia and the CXC chemokine family (Review). Exp Ther Med 9: 1572-1576, 2015.
18. Gong LY, Zhang ZY, Zheng YH and Zhang JZ: Study of a serum protein fingerprint diagnostic model in patients with hypertensive disorder complicating pregnancy. Zhonghua Fu Chan Ke Za Zhi 42: 822-825, 2007 (In Chinese).
19. Liu C, Zhang N, Yu H, Chen Y, Liang Y, Deng H and Zhang Z: Proteomic analysis of human serum for finding pathogenic factors and potential biomarkers in preeclampsia. Placenta 32: 168-174, 2011.
20. Kalkunte SS, Neubeck S, Norris WE, Cheng SB, Kostadinov S, Vu Hoang D, Ahmed A, von Eggeling F, Shaikh Z, Padbury J, et al: Transthyretin is dysregulated in preeclampsia, and its native form prevents the onset of disease in a preclinical mouse model. Am J Pathol 183: 1425-1436, 2013.
21. Zhu L, Chen Y, Liu C, Deng H, Zhang N, Wang S and Zhang Z: Transthyretin as a novel candidate biomarker for preeclampsia. Exp Ther Med 7: 1332-1336, 2014.
22. Heissig B, Hattori K, Friedrich M, Rafii S and Werb Z: Angiogenesis: vascular remodeling of the extracellular matrix involves metalloproteinases. Curr Opin Hematol 10: 136-141, 2003.
23. Omran OM, Shokry M, Ismail H, Omar G and Rezk M: Expression of matrix metalloproteinases 2 and 9 in human trophoblasts of normal and preeclamptic placentas. Int J Health Sci (Qassim) 5 (Suppl 1): 21-23, 2011.
24. Yang Y, Zhang J, Gong Y, Liu X, Bai Y, Xu W and Zhou R: Increased expression of prostasin contributes to early-onset severe preeclampsia through inhibiting trophoblast invasion. J Perinatol 35: 16-22, 2015.
25. Cockle JV, Gopichandran N, Walker JJ, Levene MI and Orsi NM: Matrix metalloproteinases and their tissue inhibitors in preterm perinatal complications. Reprod Sci 14: 629-645, 2007